BioSpace News Archive

Policy

Trump Administration’s ‘Operation Warp Speed’ Zeroes in on 14 Possible COVID-19 Vaccines

The Hill reports that the six or eight selected will go into clinical trials, where “health experts are looking to weed out faulty candidates and come out with three or four vaccines that clear final testing to be used by early 2021.”

May 4, 2020
·
3 min read
·
Mark Terry
Business

SciBase and Advanced Dermatology and Cosmetic Surgery Group Partner to Advance Skin Cancer Detection in US’ Largest Dermatology Network

SciBase announced, on “Melanoma Monday”, that they have entered into a collaboration agreement with Advanced Dermatology and Cosmetic Surgery - the premier dermatology network in the US with over 150 practices.

May 4, 2020
·
4 min read
Business

HORAMA Appoints Industry Veteran Ian Catchpole as Chief Scientific Officer

HORAMA, a clinical stage gene therapy company in ophthalmology, announced the appointment of Dr. Ian Catchpole as its Chief Scientific Officer.

May 4, 2020
·
3 min read
Pharm Country

Applied DNA and Takis Biotech Announce the Production of Neutralizing Antibodies Against SARS-CoV-2 After DNA Vaccination in Animals

Beyond expectations, a single injection of DNA in mice induced antibodies that block the infection of cultured human cells by SARS-CoV-2

May 4, 2020
·
6 min read
Pharm Country

BrainStorm Presents New Data Highlighting NurOwn® Immunomodulation in Neurology

BrainStorm Cell Therapeutics Inc. announced that new data highlighting the immunomodulatory effects of NurOwn® on B and T regulatory function appeared in an online supplement to Neurology.

May 4, 2020
·
5 min read
Business

Seoul Viosys Reports First Quarter 2020 Results

Seoul Viosys Co., Ltd., a leading global innovator of short wavelength LED products and technology, announced KRW 87 billion for consolidated revenue for the first quarter and operating profit of KRW 2.7 billion.

May 4, 2020
·
3 min read
Business

Hovione Announces the Appointment of Jean-Luc Herbeaux as Chief Operating Officer

Hovione announced today the appointment of Dr. Jean-Luc Herbeaux as Chief Operating Officer, effective May 1st, 2020.

May 4, 2020
·
2 min read
Drug Development

Aridis Pharmaceuticals Enrolls Its First COVID-19 Patient in Ongoing Phase 3 AR-301 Clinical Trial in Ventilator Associated Pneumonia (VAP)

Aridis Pharmaceuticals, Inc. announced the enrollment of its first COVID-19 patient in the Company’s ongoing Phase 3 clinical trial of AR-301, a monoclonal antibody against S. aureus induced pneumonia in patients who were already on mechanical ventilators.

May 4, 2020
·
6 min read
Deals

TLC Earns Highest Ranking in Corporate Governance Evaluation Six Years in a RowTLC is the only listed biotech company to achieve the elite status every year

TLC announced that it has been ranked in the Top 5% in Corporate Governance Evaluation amongst all Taiwan Stock Exchange Corporation and Taipei Exchange listed companies in the sixth annual evaluation, becoming the only biotech company to have received this status for six consecutive years.

May 4, 2020
·
2 min read
DNA Genotek’s ORAcollect®·RNA kit included in EUA granted to Biocerna SARS-CoV-2 test

DNA Genotek Inc., a leading provider of sample collection kits and end-to-end services and a wholly-owned subsidiary of OraSure Technologies, Inc., announced that its ORAcollect®·RNA kit was included as the collection device for anterior nares samples under a U.S.

May 4, 2020
·
3 min read